iiinova — where your digital self keeps evolving

Reposted by COVID Moonshot

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 22/09/2026

@covid-moonshot.bsky.social & @asapdiscovery.bsky.social researchers tell us how they developed innovative approaches to IP, enabling open science drug discovery while ensuring non-exclusive manufacturing & equitable access. 🎧 open.spotify.com/episode/5CBi... #UNGA81 #PandemicPrep #OpenScience

184

Reposted by COVID Moonshot

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 27/08/2026

How to unlock the power of crowdsourced science to prepare for future coronavirus pandemics? Read our latest Drug Discovery Explained story on the @covid-moonshot.bsky.social and @asapdiscovery.bsky.social #openscience initiatives: 🔗 stories.dndi.org/drug-discove... #pandemicpreparedness

042

Reposted by COVID Moonshot

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 27/03/2026

'Every two weeks we now generate more lead‑optimization structural data on #dengue than we did in the previous two decades combined. The pace of the ASAP open-source project is astounding,' said @griffen-ed.bsky.social, technical director @medchemica.com. (1/3)

164

Reposted by COVID Moonshot

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 24/09/2025

Great news! 🎉 Following an independent expert review, we have formally nominated the broad-spectrum pan-coronavirus antiviral ASAP-0017445 as a pre-clinical drug candidate. 🔗Read the press release here: dndi.org/press-releas...

01610

Reposted by COVID Moonshot

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 08/04/2025

Today, @griffen-ed.bsky.social explains at the Open Drug Discovery Symposium how @asapdiscovery.bsky.social has developed a hybrid intellectual property model that counterintuitively uses patents to support open science innovation and ensure affordability & global access. 🔗 shorturl.at/gMY0t

shorturl.at

043

Reposted by COVID Moonshot

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 04/04/2025

'We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us do that.' Read our full opinion piece co-authored by Ed Griffen (@griffen-ed.bsky.social) and Pascale Boulet ⤵️ cen.acs.org/pharmaceutic...

cen.acs.org

Opinion: How patents can serve the common good

We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us do that

064

Reposted by COVID Moonshot

C&EN (Chemical & Engineering News) @cenmag.bsky.social · 27/03/2025

At #ACSSpring2025, Ed Griffen of MedChemica disclosed the structure of a pancoronavirus antiviral that targets the main protease of the two different coronaviruses that cause Middle East respiratory syndrome (MERS) and COVID-19. cen.acs.org/acs-news/acs... 🧪

cen.acs.org

Antiviral unveiled that goes after multiple coronaviruses

Open-science consortium discloses its lead candidate to fight SARS-CoV-2 and MERS-CoV

811333

Reposted by COVID Moonshot

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 25/03/2025

📢Important announcement! Today, the @asapdiscovery.bsky.social consortium disclosed the structure of our preclinical candidate, ASAP-0017445, a promising broad-spectrum antiviral with potent activity against SARS-CoV2 and other viruses belonging to the same family. (1/10)

35021

Reposted by COVID Moonshot

The ASAP Discovery Consortium @asapdiscovery.bsky.social · 18/12/2024

If you missed previous Antiviral Drug Discovery Open Science Forum talks, you can find videos of all of them online here: asapdiscovery.org/forum/#past-...

asapdiscovery.org

Antiviral Drug Discovery (AViDD) Open Science Forum

A public venue to enable NIH-funded AViDD Centers to openly exchange and disseminate information in a pre-competitive fashion.

042

COVID Moonshot @covid-moonshot.bsky.social · 21/11/2024

The COVID-Moonshot is an open-science, crowdsourced drug discovery initiative working to develop a straight-to-generic, accessible, and affordable #COVID19 antiviral. Learn more: www.science.org/doi/10.1126/...

science.org

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

An open-science effort yields a promising noncovalent inhibitor of the SARS-CoV-2 main protease.

000